Sanofi Makes Case For Frontline Use Of Myeloma Drug Sarclisa

Promising Data In Newly Diagnosed Transplant-Eligible Patients

 
• By Kevin Grogan
Big dart
Four may be better than three when targeting multiple myeloma • Source: Alamy

More from Anticancer

More from Therapeutic Category